Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
- PMID: 32786198
- DOI: 10.1056/NEJMc2021840
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Comment in
-
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. Reply.N Engl J Med. 2020 Aug 13;383(7):695. doi: 10.1056/NEJMc2021840. N Engl J Med. 2020. PMID: 32786201 No abstract available.
Comment on
-
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical